financetom
Business
financetom
/
Business
/
Infosys likely to have shortlisted 20 acquisition targets, says report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Infosys likely to have shortlisted 20 acquisition targets, says report
Sep 17, 2018 1:00 AM

Software major Infosys has shortlisted 20 acquisition targets and will look at closing a few of the deals after evaluation over 12 to 24 months, Business Standard reported.

Infosys CEO Salil Parekh told the newspaper that the company is ramping up its organic pay methods to expand in the digital space in North America, UK and Australia.

"We have a clear idea of where we want to grow ... and if we see something fit into that requirement and we can explain it to ourselves, the board and the market, those will be done," Parekh told the paper.

When Parekh had joined the company, he had clearly stated his intentions of announcing two acquisition deals and one joint venture.

Have you signed up for Primo, our daily newsletter? It has all the stories and data on the market, business, economy and tech that you need to know.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla Expects Capital Expenditures to Surpass $11 Billion Annually Through 2027
Tesla Expects Capital Expenditures to Surpass $11 Billion Annually Through 2027
Jan 30, 2025
09:21 AM EST, 01/30/2025 (MT Newswires) -- Tesla (TSLA) said Thursday that it expects capital expenditures to surpass $11 billion this year and each of the following two years. The electric vehicle manufacturing company said in a regulatory filing that its capital spending could fluctuate depending on project priorities, production adjustments, and cost efficiencies, but that cash flow from operations...
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands
Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands
Jan 30, 2025
Thermo Fisher Scientific Inc ( TMO ) shares are trading higher in Thursday’s premarket session. The company reported fourth-quarter adjusted earnings per share of $6.10, beating the street view of $5.94. Quarterly sales of $11.395 billion (+5% year over year) outpaced the analyst consensus estimate of $11.277 billion. “We drove meaningful share gain and enabled the success of our customers,...
Levi Strauss Sees Gloomy FY25 Despite Solid Q4, Stock Slides
Levi Strauss Sees Gloomy FY25 Despite Solid Q4, Stock Slides
Jan 30, 2025
Shares of clothing major Levi Strauss & Co ( LEVI ) are trading lower in premarket on Thursday. Levi Strauss had provided a weaker outlook for FY25, expecting revenues to decline (1)% – (2)%. The company sees FY25 adjusted EPS of $1.20 – $1.25 against an estimate of $1.37. The Denim jeans maker reported a fourth-quarter FY24 sales growth of...
Tectonic Therapeutic Shares Soar Pre-Bell Following Interim Data From TX45 Trial
Tectonic Therapeutic Shares Soar Pre-Bell Following Interim Data From TX45 Trial
Jan 30, 2025
09:18 AM EST, 01/30/2025 (MT Newswires) -- Tectonic Therapeutic ( TECX ) shares climbed 90% in Thursday's premarket session after the company said a phase 1b trial showed that TX45 improved left ventricular function and pulmonary hemodynamics. The biotech firm said TX45 was well tolerated with no serious or severe adverse events, discontinuations, infusion reactions, or drug-related adverse events. These...
Copyright 2023-2026 - www.financetom.com All Rights Reserved